2Michael A. Nauck.Incretin-Based Therapies for Type 2 Diabetes Mellitus: Properties, Functions, and Clinical Implications[J].The American Journal of Medicine.2011(1)
3G. Derosa,P. Maffioli,I. Ferrari,R. Mereu,P. Ragonesi,F. Querci,I. Franzetti,G. Gadaleta,L. Ciccarelli,M. Piccinni,A. D’Angelo,S. Salvadeo.Effects of One Year Treatment of Vildagliptin Added to Pioglitazone or Glimepiride in Poorly Controlled Type 2 Diabetic Patients[J].Horm Metab Res.2010(09)
4Raffaele Marfella,Michelangela Barbieri,Rodolfo Grella,Maria Rosaria Rizzo,Giovanni Francesco Nicoletti,Giuseppe Paolisso.Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations[J].Journal of Diabetes and Its Complications.2010(2)
5N. Matikainen,S. M?ntt?ri,A. Schweizer,A. Ulvestad,D. Mills,B. E. Dunning,J. E. Foley,M.-R. Taskinen.Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes[J].Diabetologia.2006(9)
